Cargando…
Early de-escalation of DAPT after PCI: implications of the latest randomized trials in the COVID era
Autores principales: | Mahajan, Kunal, Batra, Aditya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244419/ https://www.ncbi.nlm.nih.gov/pubmed/32768026 http://dx.doi.org/10.1016/j.ihj.2020.05.009 |
Ejemplares similares
-
Risk prediction of bleeding and MACCE by PRECISE-DAPT score post-PCI
por: Dannenberg, Lisa, et al.
Publicado: (2021) -
de Winter sign–A STEMI Equivalent
por: Mahajan, Kunal, et al.
Publicado: (2018) -
Clopidogrel Monotherapy After 1-Month DAPT in Patients With High Bleeding Risk or Complex PCI
por: Yamamoto, Ko, et al.
Publicado: (2023) -
Leave pooling—the latest trend: Implications
por: Upadhyaya, Suneet Kumar, et al.
Publicado: (2011) -
Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice
por: Gragnano, Felice, et al.
Publicado: (2022)